MSB 4.69% $1.45 mesoblast limited

News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-131

  1. 30,375 Posts.
    lightbulb Created with Sketch. 1858
    The overkill and sledging in your statements are telling.

    re-do trials agin [sic]

    Did you not notice the repetition?

    Nothing you say changes the reality that we are ahead. Certainly the America First types wanted to slow down the revolution in medical treatment.

    Too many snouts in the pharmaceutical drug trough to avoid it.

    Sure, a set back has happened.

    Nothing you say changes the reality that it's not the quality of our stem cells that caused the need.

    It's the widespread use of pharmaceutical drugs that caused it.

    Talk about retrograde thinking.

    Your insults are a massive mistake. They reflect very poorly on you indeed.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.